Intraoperative Transfusion of Fresh Frozen Plasma Predicts Morbidity Following Partial Liver Resection for Hepatocellular Carcinoma

Siegel R, Naishadham D, Jemal A. Cancer statistics for Hispanics/Latinos, 2012. CA: a cancer journal for clinicians. 2012;62(5):283-98. doi:https://doi.org/10.3322/caac.21153. Lurje G, Bednarsch J, Czigany Z, Amygdalos I, Meister F, Schoning W et al. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent. Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie. 2018;403(7):851-61. doi:https://doi.org/10.1007/s00423-018-1715-9. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362(9399):1907-17. doi:https://doi.org/10.1016/S0140-6736(03)14964-1. Lurje G, Lesurtel M, Clavien PA. Multimodal treatment strategies in patients undergoing surgery for hepatocellular carcinoma. Dig Dis. 2013;31(1):112-7. doi:https://doi.org/10.1159/000347205. Czigany Z, Schoning W, Ulmer TF, Bednarsch J, Amygdalos I, Cramer T et al. Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): a prospective multicentre randomised controlled trial (HOPE ECD-DBD). BMJ Open. 2017;7(10):e017558. doi:https://doi.org/10.1136/bmjopen-2017-017558. Teh SH, Nagorney DM, Stevens SR, Offord KP, Therneau TM, Plevak DJ et al. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology. 2007;132(4):1261-9. doi:https://doi.org/10.1053/j.gastro.2007.01.040. Teh SH, Christein J, Donohue J, Que F, Kendrick M, Farnell M et al. Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2005;9(9):1207-15; discussion 15. doi:https://doi.org/10.1016/j.gassur.2005.09.008. Maithel SK, Kneuertz PJ, Kooby DA, Scoggins CR, Weber SM, Martin RC, 2nd et al. Importance of low preoperative platelet count in selecting patients for resection of hepatocellular carcinoma: a multi-institutional analysis. Journal of the American College of Surgeons. 2011;212(4):638-48; discussion 48-50. doi:https://doi.org/10.1016/j.jamcollsurg.2011.01.004. Stockmann M, Lock JF, Riecke B, Heyne K, Martus P, Fricke M et al. Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity. Annals of surgery. 2009;250(1):119-25. doi:https://doi.org/10.1097/SLA.0b013e3181ad85b5. Lurje I, Czigany Z, Bednarsch J, Roderburg C, Isfort P, Neumann UP et al. Treatment Strategies for Hepatocellular Carcinoma (-) a Multidisciplinary Approach. Int J Mol Sci. 2019;20(6). doi:https://doi.org/10.3390/ijms20061465. Nguyen KT, Marsh JW, Tsung A, Steel JJ, Gamblin TC, Geller DA. Comparative benefits of laparoscopic vs open hepatic resection: a critical appraisal. Archives of surgery. 2011;146(3):348-56. doi:https://doi.org/10.1001/archsurg.2010.248. de Graaf W, van Lienden KP, Dinant S, Roelofs JJ, Busch OR, Gouma DJ et al. Assessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resection. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2010;14(2):369-78. doi:https://doi.org/10.1007/s11605-009-1085-2. Imamura H, Sano K, Sugawara Y, Kokudo N, Makuuchi M. Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. Journal of hepato-biliary-pancreatic surgery. 2005;12(1):16-22. doi:https://doi.org/10.1007/s00534-004-0965-9. Imamura H, Seyama Y, Kokudo N, Maema A, Sugawara Y, Sano K et al. One thousand fifty-six hepatectomies without mortality in 8 years. Archives of surgery. 2003;138(11):1198-206; discussion 206. doi:https://doi.org/10.1001/archsurg.138.11.1198. Jara M, Reese T, Malinowski M, Valle E, Seehofer D, Puhl G et al. Reductions in post-hepatectomy liver failure and related mortality after implementation of the LiMAx algorithm in preoperative work-up: a single-centre analysis of 1170 hepatectomies of one or more segments. HPB : the official journal of the International Hepato Pancreato Biliary Association. 2015;17(7):651-8. doi:https://doi.org/10.1111/hpb.12424. Takayama T. Surgical treatment for hepatocellular carcinoma. Japanese journal of clinical oncology. 2011;41(4):447-54. doi:https://doi.org/10.1093/jjco/hyr016. Hanazaki K, Kajikawa S, Shimozawa N, Mihara M, Shimada K, Hiraguri M et al. Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. Journal of the American College of Surgeons. 2000;191(4):381-8. Mizuguchi T, Kawamoto M, Meguro M, Nakamura Y, Ota S, Hui TT et al. Prognosis and predictors of surgical complications in hepatocellular carcinoma patients with or without cirrhosis after hepatectomy. World journal of surgery. 2013;37(6):1379-87. doi:https://doi.org/10.1007/s00268-013-1989-6. Doussot A, Lim C, Lahat E, Salloum C, Osseis M, Gavara CG et al. Complications after Hepatectomy for Hepatocellular Carcinoma Independently Shorten Survival: A Western, Single-Center Audit. Annals of surgical oncology. 2017;24(6):1569-78. doi:https://doi.org/10.1245/s10434-016-5746-6. Bednarsch J, Czigany Z, Lurje I, Tacke F, Strnad P, Ulmer TF et al. Left- versus right-sided hepatectomy with hilar en-bloc resection in perihilar cholangiocarcinoma. HPB : the official journal of the International Hepato Pancreato Biliary Association. 2019. doi:https://doi.org/10.1016/j.hpb.2019.07.003. Lurje G, Bednarsch J, Czigany Z, Lurje I, Schlebusch IK, Boecker J et al. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma. Eur J Surg Oncol. 2019. doi:https://doi.org/10.1016/j.ejso.2019.04.019. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Annals of surgery. 2004;240(2):205-13. Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D et al. The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Annals of surgery. 2005;242(6):824-8, discussion 8-9. Katz SC, Shia J, Liau KH, Gonen M, Ruo L, Jarnagin WR et al. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Annals of surgery. 2009;249(4):617-23. doi:https://doi.org/10.1097/SLA.0b013e31819ed22f. Shiba H, Ishida Y, Wakiyama S, Iida T, Matsumoto M, Sakamoto T et al. Negative impact of blood transfusion on recurrence and prognosis of hepatocellular carcinoma after hepatic resection. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2009;13(9):1636-42. doi:https://doi.org/10.1007/s11605-009-0963-y. Harada N, Shirabe K, Maeda T, Kayashima H, Ishida T, Maehara Y. Blood transfusion is associated with recurrence of hepatocellular carcinoma after hepatectomy in Child-Pugh class A patients. World journal of surgery. 2015;39(4):1044-51. doi:https://doi.org/10.1007/s00268-014-2891-6. Yang T, Lu JH, Lau WY, Zhang TY, Zhang H, Shen YN et al. Perioperative blood transfusion does not influence recurrence-free and overall survivals after curative resection for hepatocellular carcinoma: A Propensity Score Matching Analysis. Journal of hepatology. 2016;64(3):583-93. doi:https://doi.org/10.1016/j.jhep.2015.10.012. Kuroda S, Tashiro H, Kobayashi T, Oshita A, Amano H, Ohdan H. No impact of perioperative blood transfusion on recurrence of hepatocellular carcinoma after hepatectomy. World journal of surgery. 2012;36(3):651-8. doi:https://doi.org/10.1007/s00268-012-1425-3. de Boer MT, Molenaar IQ, Porte RJ. Impact of blood loss on outcome after liver resection. Digestive surgery. 2007;24(4):259-64. doi:https://doi.org/10.1159/000103656. Bennett S, Baker L, Shorr R, Martel G, Fergusson D. The impact of perioperative red blood cell transfusions in patients undergoing liver resection: a systematic review protocol. Syst Rev. 2016;5:38. doi:https://doi.org/10.1186/s13643-016-0217-5. Takagi T, Kajiro K, Yazawa Y, Takada Y, Takeda T, Teratani M et al. A Study on appropriate usage of fresh frozen plasma and albumin for patients in internal medicine. Journal of the Japan Society of Blood Transfusion. 2004;50(6). Tomimaru Y, Wada H, Marubashi S, Kobayashi S, Eguchi H, Takeda Y et al. Fresh frozen plasma transfusion does not affect outcomes following hepatic resection for hepatocellular carcinoma. World journal of gastroenterology : WJG. 2010;16(44):5603-10. Kaibori M, Saito T, Matsui K, Yamaoka M, Kamiyama Y. Impact of fresh frozen plasma on hepatectomy for hepatocellular carcinoma. Anticancer research. 2008;28(3B):1749-55. Shiba H, Ishida Y, Haruki K, Furukawa K, Fujiwara Y, Iwase R et al. Negative impact of fresh-frozen plasma transfusion on prognosis after hepatic resection for liver metastases from colorectal cancer. Anticancer research. 2013;33(6):2723-8. Qiu L, Wang DR, Zhang XY, Gao S, Li XX, Sun GP et al. Impact of perioperative blood transfusion on immune function and prognosis in colorectal cancer patients. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis. 2016;54(2):235-41. doi:https://doi.org/10.1016/j.transci.2015.07.004. Shiba H, Ishii Y, Ishida Y, Wakiyama S, Sakamoto T, Ito R et al. Assessment of blood-products use as predictor of pulmonary complications and surgical-site infection after hepatectomy for hepatocellular carcinoma. Journal of hepato-biliary-pancreatic surgery. 2009;16(1):69-74. doi:https://doi.org/10.1007/s00534-008-0006-1. Fernandez J, Acevedo J, Wiest R, Gustot T, Amoros A, Deulofeu C et al. Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis. Gut. 2017. doi:https://doi.org/10.1136/gutjnl-2017-314240. Meybohm P, Zacharowski K, Weber CF. Point-of-care coagulation management in intensive care medicine. Critical care. 2013;17(2):218. doi:https://doi.org/10.1186/cc12527. Weeder PD, Porte RJ, Lisman T. Hemostasis in liver disease: implications of new concepts for perioperative management. Transfus Med Rev. 2014;28(3):107-13. doi:https://doi.org/10.1016/j.tmrv.2014.03.002. Sarani B, Dunkman WJ, Dean L, Sonnad S, Rohrbach JI, Gracias VH. Transfusion of fresh frozen plasma in critically ill surgical patients is associated with an increased risk of infection. Critical care medicine. 2008;36(4):1114-8. doi:https://doi.org/10.1097/CCM.0b013e318168f89d. Refaai MA, Blumberg N. Transfusion immunomodulation from a clinical perspective: an update. Expert Rev Hematol. 2013;6(6):653-63. doi:https://doi.org/10.1586/17474086.2013.850026. Vibert E, Ishizawa T. Hepatocellular carcinoma: Western and Eastern surgeons' points of view. Journal of visceral surgery. 2012;149(5):e302-6. doi:https://doi.org/10.1016/j.jviscsurg.2012.05.001. Herman P, Coelho FF. Laparoscopic resection for hepatocellular carcinoma: eastern and western experiences. Chin J Cancer Res. 2014;26(3):234-6. doi:https://doi.org/10.3978/j.issn.1000-9604.2014.06.19.